Direktorat Registrasi ObatValid

LAMIVUDINE

Claim this product
BPOM Number
GKL1112425210A1
Approved
21 November 2024
Expiry
22 June 2027
Form
TABLET; 100 MG

About This Registration

LAMIVUDINE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1112425210A1. Its current registration status is Valid, with the licence valid until 22 June 2027. The product is registered to KIMIA FARMA TBK. - INDONESIA. BPOM first approved this registration in June 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 BOTOL PLASTIK @ 30 TABLET
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

LAMIVUDINE

Market Intelligence

Owner Portfolio
KIMIA FARMA TBK. - INDONESIA holds 355 BPOM registrations
Manufacturer Scale
KIMIA FARMA TBK. - INDONESIA produces 355 registered products
Registration Age
Registered for 4 years, 3 months
Expiry Status
Expires in 9 months

FDA Cross-Reference

via openFDA
Generic Name
LAMIVUDINE AND ZIDOVUDINE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1